| AS20010013 | 注射用因福利美 | infliximab | Lyophilized | Biological Products | New Drug Application | 2003-09-19 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Approval Completed-Pending Certificated | 2003-12-17 | view |
| CXSS2000004 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(2) | New Drug Application | 2020-02-14 | 泰州迈博太科药业有限公司 | Taizhou Maibotaike Pharmaceutical Co Ltd | In Approval | 2021-07-05 | view |
| CXSS2000020 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(2) | New Drug Application | 2020-05-15 | 海正生物制药有限公司 | Hisun Biopharmaceutical Co Ltd | Certificate Issued | 2021-09-28 | view |
| CXSS2000054 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(3.3) | New Drug Application | 2020-11-04 | 玉溪嘉和生物技术有限公司 | Yuxi Genor Biotechnology Co Ltd | In Review | 2020-11-03 | view |
| CYSB2200185 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(原2) | Supplementary Application | 2022-08-01 | | Taizhou Maibotaike Pharmaceutical Co Ltd | | | view |
| CYSB2200234 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(原2) | Supplementary Application | 2022-09-23 | | Hisun Biopharmaceutical Co Ltd | | | view |
| CYSB2300025 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2023-02-01 | | Yuxi Genor Biotechnology Co Ltd | | | view |
| CYSB2300117 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(原2) | Supplementary Application | 2023-06-15 | | Taizhou Maibotaike Pharmaceutical Co Ltd | | | view |
| CYSB2400028 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2024-01-31 | | Taizhou Maibotaike Pharmaceutical Co Ltd | | | view |
| CYSB2400172 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(原2) | Supplementary Application | 2024-07-05 | | Hisun Biopharmaceutical Co Ltd | | | view |
| J0402107 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(7) | Import Drug Application | 2004-11-10 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Completed-Pending Issued | 2006-05-26 | view |
| JXSL0700014 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(2) | Import Drug Application | 2007-05-11 | Centocor B.V. | Centocor BV | Certificate Issued | 2008-06-20 | view |
| JXSL1300082 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Import Drug Application | 2014-01-03 | 精鼎医药研究开发（上海）有限公司 | Parexel China Co Ltd | Certificate Issued | 2017-04-06 | view |
| JXSS1000018 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Import Drug Application | 2010-11-04 | Centocor B.V. | Centocor BV | Certificate Issued | 2013-08-22 | view |
| JXSS1400009 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Import Drug Application | 2014-11-17 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2015-05-04 | view |
| JXSS1500015 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Import Drug Application | 2015-11-23 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2018-12-29 | view |
| JXSS2100022 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(3.3) | Import Drug Application | 2021-04-02 | CELLTRION, Inc. | Celltrion Inc | In Review | 2021-04-02 | view |
| JYSB0600066 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2006-06-23 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2007-02-26 | view |
| JYSB1400228 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2014-11-24 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2015-07-13 | view |
| JYSB1500077 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2015-04-10 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd | Certificate Issued | 2015-09-11 | view |
